• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Radiology Classics

CT scans increase the risk of malignancy in children and young adults [Classics Series]

byDeepti Shroff Karhade
August 15, 2022
in Radiology Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. In this retrospective cohort analysis of children and young adults without previous malignancy, patients exposed to multiple computed tomography (CT) scans had over 3 times the risk of developing leukemia and brain tumors.

Original Date of Publication: August 2012

Study Rundown: While the connection between radiation exposure and malignancy was previously identified, research on the subject matter drew from high-dose radiation exposure secondary to atomic bombs in Japan. At the time of its publication, this study was the first to use a cohort to examine the malignancy risk associated with low-dose radiation from CT scans. Through retrospective analysis, researchers investigated the relationship between CT-induced radiation exposure during childhood and young adulthood and development of leukemia and brain cancer, as these malignancies occur in particularly radiosensitive tissue. Children under the age of 15 who received 5-10 head CTs were exposed to around 50 milligrays (mGy) of radiation to their marrow, while 2-3 head CTs exposed these children to about 60 mGy of brain radiation. For comparison, the average chest radiograph exposes a child to 0.05 to 0.3 mGy.

Investigators reported an over 3 times increased risk of developing leukemia with exposure to ≥30 mGy and developing a brain tumor with ≥50 mGy of radiation. Limitations included using standardized CT machine settings as a proxy when assessing radiation exposure due to missing data regarding machine-specific settings. However, the use of a cohort from Great Britain’s national database ensured a large study group with low risk of loss to follow-up. This was the first cohort study to investigate the potential association between lower doses of radiation than the estimated 100 mGy of radiation exposure experienced by many Japanese atomic bomb victims. While the overall incidence of these malignancies is small within the pediatric population, this study does indicate significant risks associated with over-imaging developing children. With this in mind, the Alliance for Radiation Safety in Pediatric Imaging within the United States has started the “Image Gently” campaign, a movement designed to increase awareness of healthcare practitioners and caregivers to the benefits of reducing unnecessary radiation exposure.

Click to read the study in The Lancet

RELATED REPORTS

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

#VisualAbstract: Blinatumomab Improves Survival in MRD-Negative Acute Lymphoblastic Leukemia in Adults

In-Depth [retrospective cohort]: A total of 355 191 patients seen at a Great Britain National Health Service hospital without a history of prior malignancy, but who underwent a first CT scan between 1985-2002 at ages younger than 22, were included in the study. The study group was divided such that 178 604 patients were investigated with respect to leukemia and 176 587 patients were studied with respect to brain tumors. Malignancies investigated included acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndromes (MDS), leukemia excluding MDS, gliomas, meningiomas, and schwannomas. Relative risks were calculated to assess the relationship between the radiation doses expressed in mGy units and malignancy. Data were collected from a national registry and ended on December 31, 2008, at time of death, or when patients were lost to follow-up. During analysis, radiation doses were adjusted to reflect the time it typically takes to develop a malignancy. This resulted in a 2 year lag for leukemia and a 5 year lag for brain tumors.

Among the patients included in the leukemia analysis, 283 919 CT scans were completed (64% head) and 74 patients had developed leukemia on follow-up.  279 824 scans were completed for patients included in brain tumor analysis with 135 patients ultimately receiving diagnoses of brain tumors on follow-up. Significant positive associations between leukemia and CT radiation dosing (p <0.01) and brain tumors and radiation (p <0.001) were observed. Mean radiation dose was 51.13 mGy for patients who developed leukemia and with exposure to ≥30 mGy of radiation. Among those who received ≥30 mGy, patients were more than 3 times as likely to develop leukemia when compared to those who received <5 mGy (RR 3.18; 95%CI 1.46-6.94). Mean radiation dose for patients who received ≥50 mGy and developed brain tumors was 104.16 mGy. Those who received ≥50 mGy of radiation were at greater than 3 times the risk of developing a brain tumor when compared to those who were exposed to <5 mGy (RR 3.32; 95%CI 1.84-6.42).

Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumors: a retrospective cohort. The Lancet. 2012 Aug 4;380(9840):499–505.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: brain tumorctleukemiamalignancy
Previous Post

Weighted blankets may reduce sleep medication use in psychiatric patients

Next Post

Criteria for low-dose computed tomography lung cancer screening omit a high risk population of smokers

RelatedReports

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Hematology

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

May 20, 2025
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Oncology

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

March 20, 2025
#VisualAbstract: Blinatumomab Improves Survival in MRD-Negative Acute Lymphoblastic Leukemia in Adults
StudyGraphics

#VisualAbstract: Blinatumomab Improves Survival in MRD-Negative Acute Lymphoblastic Leukemia in Adults

August 5, 2024
#VisualAbstract: Chronic Lymphocytic Leukemia (CLL) therapy with Ibrutinib and Venetoclax guided by measurable residual disease improves progression-free survival
StudyGraphics

#VisualAbstract: Chronic Lymphocytic Leukemia (CLL) therapy with Ibrutinib and Venetoclax guided by measurable residual disease improves progression-free survival

January 31, 2024
Next Post
Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Criteria for low-dose computed tomography lung cancer screening omit a high risk population of smokers

Brain lesions on MRI linked with subsequent increased stroke risk

Cinpanemab therapy does not prevent Parkinson’s disease progression

Pediatric DKA associated with recent acute care visits

Dulaglutide improves glycemic control for youth with type 2 diabetes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]
  • Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF
  • #VisualAbstract: Efruxifermin Did Not Reduce Liver Fibrosis in Compensated Liver Cirrhosis Caused by MASH
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.